As of Feb 28, 2026, Cannabis Bioscience International Holdings, Inc. had total assets of $1,544 and total liabilities of $1.5 million. Total assets were down 89.6% from a year earlier. Stockholders' equity was negative, at -$1.5 million, because liabilities exceed assets. It held $90 in cash and investments against $290,865 of total debt, net debt of $290,775. The current ratio, current assets divided by current liabilities, was 0.00.
USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the year before.
| Line |
FY 2026
Feb 28, 2026
|
FY 2025
May 31, 2025
|
FY 2024
May 31, 2024
|
|---|---|---|---|
| Assets | |||
| Cash |
0
-83.6%
|
0
+1615.5%
|
0
|
| Cash and investments |
0
-83.6%
|
0
+1615.5%
|
0
|
| Receivables |
0
-52.0%
|
0
-68.3%
|
0
|
| Total current assets |
0
-59.2%
|
0
+35.3%
|
0
|
| Total assets |
0
-89.6%
|
0
-44.2%
|
0
|
| Liabilities and equity | |||
| Total current liabilities |
1
+25.7%
|
1
+7.3%
|
1
|
| Total liabilities |
1
+18.4%
|
1
+5.2%
|
1
|
| Stockholders' equity |
-1
-19.7%
|
-1
-7.8%
|
-1
|
| Debt | |||
| Debt due within a year |
0
+183.5%
|
0
+420.1%
|
0
|
| Long-term debt |
0
-0.0%
|
0
+0.1%
|
0
|
| Lease liabilities |
0
-100.0%
|
0
-81.7%
|
0
|
| Total debt |
0
+5.0%
|
0
+2.8%
|
0
|
| Net cash |
-0
-5.2%
|
-0
+1.6%
|
-0
|
| Ratios | |||
| Current ratio |
0.00x
|
0.03x
|
0.02x
|
| Return on assets |
-33,373.70%
|
-1,721.52%
|
-1,139.47%
|
| Book value per share |
-0.00
|
-0.00
|
-0.00
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. The first column is the latest balance sheet when it is newer than the latest fiscal year. More on our methodology.
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- CBIH (OTC)
- Fiscal year ends
- May 31
- Incorporated in
- CO
- Headquarters
- Yantis, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1411057
- Former names
- CHINA INFRASTRUCTURE CONSTRUCTION Corp (until Aug 24, 2022); FIDELITY AVIATION CORP (until Sep 15, 2009)
Other Services-Commercial Physical & Biological Research companies
- Iqvia Holdings Inc. IQV
- Incyte Corp INCY
- Medpace Holdings, Inc. MEDP
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- Absci Corp ABSI
- OmniAb, Inc. OABI
- NRC Health NRC
All 17 Services-Commercial Physical & Biological Research companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.